NEW YORK, March 28 (GenomeWeb News) - Proteomics company Power3 Medical Products and New Horizons Diagnostics plan to use Power3's protein biomarkers to co-develop antibody-based diagnostics for neurodegenerative diseases, the firms said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.